1. Home
  2. MYSZ vs ONCO Comparison

MYSZ vs ONCO Comparison

Compare MYSZ & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

HOLD

Current Price

$0.87

Market Cap

3.8M

Sector

Technology

ML Signal

HOLD

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$1.96

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYSZ
ONCO
Founded
1999
2018
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
4.3M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
MYSZ
ONCO
Price
$0.87
$1.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
343.5K
37.9K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,512,000.00
$1,223,751.00
Revenue This Year
$29.71
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$2.10
52 Week High
$9.40
$179.35

Technical Indicators

Market Signals
Indicator
MYSZ
ONCO
Relative Strength Index (RSI) 38.58 35.11
Support Level $0.96 $2.53
Resistance Level $0.96 $3.22
Average True Range (ATR) 0.08 0.33
MACD 0.00 -0.03
Stochastic Oscillator 2.83 4.17

Price Performance

Historical Comparison
MYSZ
ONCO

About MYSZ My Size Inc.

My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Share on Social Networks: